Nephron Pharmaceuticals Corporation

Nephron Pharmaceuticals Corporation

4500 12th St Ext, West Columbia, SC 29172, United States

Budesonide Inhalation Suspension 0.25 mg

Budesonide Inhalation Suspension 0.25 mg

Budesonide Inhalation Suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age.

Budesonide Inhalation Suspension 0.25 mg / 2mL

0487-9601-01 (30 individually wrapped and barcoded vials)

0487-9601-30 (30 bulk wrapped vials)

Each unit dose is:

Sterile unit dose

Bar coded

Foil pouched and embossed vials for easy identification

Product Enquiry

SSL Secure Connection